Good morning :)
$
₹
OrganiGram Holdings Inc

OrganiGram Holdings Inc

OGI

NASDAQ
Asset Logo

OrganiGram Holdings Inc

OGI

NASDAQ
$0.960.59% (+0.00)
$
₹
$0.960.59% (+0.00)
High
—
—
Low
—
—
Returns
—
—
Loading...
1D
1W
1M
3M
6M
1Y
3Y
5Y
Max

Healthcare

Drug Manufacturers - Specialty & Generic

Micro Cap

With a market cap of $135.4M the stock is ranked 4511

Key Metrics

Key Metrics

PE TTM
PE TTM

Close price divided by the earnings per share for the trailing twelve months

2.18
PB
PB

Close price divided by the book value per share at the end of the most recent quarter

0.39
EPS TTM
EPS TTM

Net profit earned per share over the trailing twelve months (sum of the last 4 quarters)

$0.43
PEG Ratio
PEG Ratio

Price-to-Earnings (P/E) ratio divided by the forecasted annual earnings per share (EPS) growth rate over the next five years

—
Profit Margin
Profit Margin

Net profit divided by the total revenue for the most recent financial year

28.02%
Dividend Yield
Dividend Yield

Annual dividend per share for the trailing twelve months divided by the close price

—

Analyst Ratings & Forecast

Analyst Ratings & Forecast

Detailed Forecast Detailed Forecast 

Based on 5 analysts reports

Buy
4 analysts
Hold
1 analyst
Sell
0 analyst

Price Upside

+816.19%

Earnings Growth

+374.38%

Rev. Growth

+87.95%

See Detailed Forecast

Company Profile

Company Profile

Organigram Global Inc. engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, beverages, gummies, and concentrates; and adult use recreational cannabis under the SHRED, Big Bag O' Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co., Boxhot, Edison JOLTS, Wola, Rizzlers, DEBUNK, Tremblant, and Laurentian brands. The company also engages in the wholesale shipping of cannabis plant cuttings and dried flowers to other licensed producers. It sells cannabis products to wholesale and retail channels in the recreational and medical cannabis regimes, as well as through online. Organigram Global Inc. was formerly known as Organigram Holdings Inc. and changed its name to Organigram Global Inc. in March 2025. The company is headquartered in Toronto, Canada.
Organigram Global Inc. engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, beverages, gummies, and concentrates; and adult use recreational cannabis under the SHRED, Big Bag O' Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co., Boxhot, Edison JOLTS, Wola, Rizzlers, DEBUNK, Tremblant, and Laurentian brands. The company also engages in the wholesale shipping of cannabis plant cuttings and dried flowers to other licensed producers. It sells cannabis products to wholesale and retail channels in the recreational and medical cannabis regimes, as well as through online. Organigram Global Inc. was formerly known as Organigram Holdings Inc. and changed its name to Organigram Global Inc. in March 2025. The company is headquartered in Toronto, Canada.

Peers

Compare with peers Compare with peers 

Peers

Compare with peers Compare with peers 
Eli Lilly and Company
LLY
Eli Lilly and Company
P/E Ratio
42.94
42.94
1Y Return
69.1%
69.1%
Buy Reco %
83.87
83.87
Johnson & Johnson
JNJ
Johnson & Johnson
P/E Ratio
40.77
40.77
1Y Return
48.41%
48.41%
Buy Reco %
69.56
69.56
Merck & Company Inc
MRK
Merck & Company Inc
P/E Ratio
112.55
112.55
1Y Return
69.01%
69.01%
Buy Reco %
70.37
70.37
Novartis AG ADR
NVS
Novartis AG ADR
P/E Ratio
29.93
29.93
1Y Return
32.26%
32.26%
Buy Reco %
41.66
41.66
AstraZeneca PLC
AZN
AstraZeneca PLC
P/E Ratio
25.42
25.42
1Y Return
3.56%
3.56%
Buy Reco %
83.33
83.33
Compare with Peers

Forecast

Forecast

Price

Revenue

Earnings

Price Forecast

Price Forecast

Higher price growth forecast versus trailing 3-year CAGR
Compares analyst forecast growth with historical annualized growth.

The 12-month consensus target implies 816.19% growth, versus a trailing 3-year CAGR of -2.62%.

2026
Current$0.96Baseline
Analyst Target - 1 year
Target$8.8+816.19%

All values in $

202220232024202520262027$3.07$5.27$7.48Target+816.19%
2026
Current$0.96Baseline
Analyst Target - 1 year
Target$8.8+816.19%

All values in $

Revenue Forecast

Revenue Forecast

Higher revenue growth forecast versus trailing 3-year CAGR
Compares analyst forecast growth with historical annualized growth.

The next fiscal year's mean estimate implies 87.95% growth, versus a trailing 3-year CAGR of 8.47%.

2025
Current$186.09Baseline
Forecast for Sep 2026
High$351.6+88.94%
Average$349.76+87.95%
Low$346.9+86.41%

All values in $ Million

20212022202320242025202679.16145.80149.20159.84186.09Low+86.41%Average+87.95%High+88.94%
2025
Current$186.09Baseline
Forecast for Sep 2026
High$351.6+88.94%
Average$349.76+87.95%
Low$346.9+86.41%

All values in $ Million

Earnings Per Share Forecast

Earnings Per Share Forecast

2025
Current$-0.16Baseline
Forecast for Sep 2026
High$0.44+374.38%
Average$0.44+374.38%
Low$0.44+374.38%

All values in $

202120222023202420252026-0.75-0.33-0.57-0.3-0.16Low+374.38%Average+374.38%High+374.38%
2025
Current$-0.16Baseline
Forecast for Sep 2026
High$0.44+374.38%
Average$0.44+374.38%
Low$0.44+374.38%

All values in $

Financials

Financials

Income

Balance Sheet

Cash Flow

80
-37.9
63.4
19.9
59.7
-0.9
105.7
105.5
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Revenue
Net Income
Financial YearQ1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026
Total Revenue37.6241.0644.6942.7365.670.7980.0663.4859.79105.78
Net Income-27.072.81-5.43-22.9542.45-6.29-37.9619.95-0.92105.53
Net Profit Margin-71.95%6.86%-12.15%-53.72%64.71%-8.89%-47.41%31.42%-1.54%99.76%
See CostsAll values in $ Million

Peers

Peers & Comparison

Peers & Comparison

Comparing 2 stocks from
HealthcareDrug Manufacturers - Specialty & Generic

Valuation

Returns

Forecast

ScreenerCompare valuation on Screener
StockPE TTMPE TTMPBPBPEG RatioPEG Ratio
OrganiGram Holdings Inc 2.180.39-
Eli Lilly and Company42.9433.651.22
Johnson & Johnson40.777.862.99
ScreenerCompare valuation on Screener

Price Comparison

Price Comparison

Compare OGI with any stock or ETF
Compare OGI with any stock or ETF
Comparing from
OGI
LLY
JNJ
Loading...

Frequently asked questions

  1. OrganiGram Holdings Inc (OGI) share price today is $0.96 as of October 30, 2026 at 1:30 AM IST. The stock touched a day high of $0.97 and a day low of $0.94.

  2. OrganiGram Holdings Inc stock trades on NASDAQ under the ticker symbol OGI.

  3. OrganiGram Holdings Inc's market capitalization is $135.38M as of October 30, 2026 at 1:30 AM IST.

  4. OrganiGram Holdings Inc's price-to-earnings (P/E) ratio is 2.18 as of October 29, 2026.

  5. OrganiGram Holdings Inc's price-to-book (P/B) ratio is 0.39 as of October 29, 2026.

  6. Yes, You can buy OrganiGram Holdings Inc shares from India through Tickertape, via our partnership with ViewTrade IFSC under the IFSCA Global Access framework, subject to RBI’s Liberalised Remittance Scheme (LRS) limits.

  7. Indian investors can buy OrganiGram Holdings Inc shares in three steps: 1. Search OrganiGram Holdings Inc on the Tickertape app and tap Invest. 2. Complete your one-time digital KYC. 3. Fund your account and buy from as low as $1 via fractional shares.

  8. Since OrganiGram Holdings Inc trades in USD, an Indian investor's INR returns depend on both the stock's price movement and the USD-INR exchange rate. If the rupee depreciates against the dollar, INR returns are boosted beyond the stock's USD return; if the rupee appreciates, INR returns are reduced.

  9. Indian investors can start investing in OrganiGram Holdings Inc (OGI) shares from as little as $1 through fractional ownership on Tickertape - for example, $10 buys approximately 10.4058 shares at the current price of $0.96.

Loading...